Cerrahi Rezeksiyon Sonrası Sonuçlarla, Pulmoner Karsinoid Tümörlerin Tedavi Protokollerinin ve Sağkalımın Araştırılması

Öz

Amaç: Pulmoner karsinoid tümörler; akciğerler içinde nöroendokrin tipte olan Kultschitzky hücrelerinden kaynaklanan ve tüm akciğer tümörlerinin sadece %1-2ʼsini oluşturan malign neoplazmlardır.Çalışmada akciğer karsinoid tümörlerin klinik özellikleri, tedavi protokolleri ve prognostik faktörleri incelendi.Gereç ve Yöntemler: Geriye dönük çalışmaya kliniğimizde Ocak 2010 ile Temmuz 2017 tarihleri arasında patoloji raporları ile karsinoid tümör tanısı alan olgular dahil edildi. Hastaların cinsiyetleri, yaşları, şikâyetleri, tedavide uygulanan cerrahi teknik, hücre tipi, tümörün yerleşim yeri, tümör çapı, lenf nodu ve uzak organ metastaz varlığı, karşılaşılan komplikasyonlar ve sağkalım süreleri incelendi. Bulgular: Çalışmadaki 23 hastanın ortalama yaşları 49,5 ± 13,6’dı. Hastaların 15 %65,2 tanesi kadın 8 %34,8 tanesi erkekti. Hastaların 19 %82,6 tanesinde öksürük, balgam ve hemoptizi gibi solunum yolu semptomları mevcuttu. Tümör yerleşimi açısından bakıldığında en sık yerleşim yeri sağ alt lob %34,7 olarak bulundu. Yapılan cerrahi işlemler sonrasında hiçbir hastada mortalite ve morbidite izlenmedi. Sadece iki hastada lenf nodu veya uzak organ metastazı saptanmış olup bu hastaların atipik karsinoid tümör tanısı aldığı görüldü. Operasyon sonrası yirmibeşinci ve otuzbirinci aylarda atipik karsinoid tümör tanısı alan iki hasta eksitus oldu. Bunlardan bir tanesinde lenf nodu ve uzak organ metastazı saptanmıştı. Sonuç: Medikal tedaviye yanıt alınamayan öksürük, balgam ve nefes darlığı gibi semptomlarda karsinoid tümör tanısı düşünülmelidir. Cerrahi eksizyon sırasında cerrahi sınırlarda tümör kalmamasına özen gösterilmeli ve preoperatif tanısı ne olursa olsun her hastaya mediastinal lenf nodu disseksiyonu yapılmalıdır. Çalışmamızda sağkalımı belirleyen en önemli faktörlerin histolojik tip ve uzak organ metastazı ve lenf nodu tutulumu olduğu bulundu

Anahtar Kelimeler

• Akciğer, Atipik, Karsinoid, Sağkalım, Tipik

Investigation of Treatment Protocols and Survival of Pulmonary Carcinoid Tumors with Results After Surgical Resection

Öz

Objective: Pulmonary carcinoid tumors are malignant neoplasms originating from Kultschitzky cells of the neuroendocrine type in the lungs and constituting only 1-2% of all lung tumors.The clinical features, treatment protocols and prognostic factors of lung carcinoid tumors were evaluated in this study.Material and Methods: This retrospective study included pathology reports and cases with a carcinoid tumor diagnosis between January 2010 and July 2017 in our clinic. The sex, age, complaints, surgical technique, cell type, site of tumor, tumor diameter, lymph node and distant organ metastasis, encountered complications, and survival time were analyzed.Results: The mean age of the 23 patients in the study was 49.5 ± 13.6 years. Fifteen 65.2% of the patients were female and 8 34.8% were male. Nineteen 82.6% of the patients had respiratory symptoms such as cough, sputum and hemoptysis.The most common site of tumor placement was the right lower lobe 34.7% . No mortality and morbidity were observed in any of the patients after the surgical procedures performed. Two patients who had atypical carcinoid tumor diagnosis at the twenty-fifth and thirty-first months postoperatively died. One of them had lymph node and distant organ metastasis. Lymph node or distant organ metastasis was found in only two patients and these patients were diagnosed with atypical carcinoid tumor. Conclusion: A carcinoid tumor diagnosis should be considered when symptoms such as cough, sputum and shortness of breath that cannot be resolved with medical treatment are present. During surgical excision, one must be careful not to leave tumor at the surgical margin and a mediastinal lymph node dissection should be performed in every patient regardless of the preoperative diagnosis. The most important factors determining survival in our study were histological type, lymph node involvement and distant organ metastasis.

Anahtar Kelimeler

• Atypical, Carcinoid, Lung, Survival, Typical

Kaynakça

1. Yang Z, Wang Z, Duan Y, Xu S. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung. Thorac Cancer 2016;7(6):633-8.
2. Boyacı H, Çörtük M, Gül Ş, Tanrıverdi E, Özgül MA, Dinçer HE, Çetinkaya E. Results of bronchoscopic excision in typical carcinoid tumors of the lung in Turkey. Med Glas (Zenica). 2017;14:61-6.
3. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998;22(8):934-44.
4. Cao C, Yan TD, Kennedy C, Hendel N, Bannon PG, McCaughan BC. Bronchopulmonary carcinoid tumors: long-term outcomes after resection. Ann Thorac Surg 2011; 91:339-43.
5. Filosso PL, Guerrera F, Evangelista A, Welter S, Thomas P, Casado PM, Rendina EA, Venuta F, Ampollini L, Brunelli A, Stella F, Nosotti M, Raveglia F, Larocca V, Rena O, Margaritora S, Ardissone F, Travis WD, Sarkaria I, Sagan D. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group. Eur J Cardiothorac Surg 2015;48:441-7.
6. Yazici Z, Topal U, Gebitekin C, Tolunay S, Tuncel E. Bronchial carcinoids: clinical and radiological findings. Turk J Diagn Intervent Radiol 2001;7:359-65.
7. Thomas R, Christopher DJ, Balamugesh T, Shah A. Clinico-pathologic study of pulmonary carcinoid. A retrospec-tive analysis and review of the literature. Respir Med 2008;102(11):1611-4.
8. Nguyen GK. Cytopathology of pulmonary carcinoid tumors in sputum and bronchial brushings. Acta Cytol 1995;39:1152-60.

9. Thomas JSJ, Lamb D, Ashcroft T, Corrin B , Edwards CW , Gibbs AR, Kenyon WE, Stephens RJ, Whimster WF. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR lung cancer working party. Thorax 1993;48:1135-9.
10. Davila DG, Dunn WF, Tazelaar HD, Pairolero PC. Bronchial carcinoid tumors. Mayo Clin Proc 1993;68:795- 803.
11. Pelosi G, Rodriguez J, Viale G, Rosai J. Typical and atypical pulmonary carcinoid tumor over diagnosed as small-cell carcinoma on biopsy specimens. Am J Surg Pathol 2005;29(2):179-87.
12. Mezzetti M, Raveglia F, Panigalli T, Giuliani L, Giudice FL, Meda S, Conforti S. Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann Thorac Surg 2003; 76:1838-42.
13. Fox M1, Van Berkel V, Bousamra M 2nd, Sloan S, Martin RC 2nd. Surgical management of pulmonary carcinoid tumors: Sublobar resection versus lobectomy. Am J Surg 2013;205:200-8.
14. Ferguson MK, Landreneau RJ, Hazelrigg SR, Altorki NK, Naunheim KS, Zwischenberger JB, Kent M, Yim AP. Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg 2000;18(2):156-61.
15. Thomas C, Tazelaar H, Jett J. Typical and atypical pulmonary carcinoids: Outcome in patients presenting with regional lymph node involvement. Chest 2001;119:1143-50.
16. Wurtz A, Benhamed L, Conti M, Bouchindhomme B, Porte H. Results of systematic nodal dissection in typical and atypical carcinoid tumors of the lung. J Thorac Oncol 2009;4:388-94.
17. Zhong CX, Yao F, Zhao H, Shi JX, Fan LM. Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years’ experience with 131 patients. Chin Med J 2012; 125: 3022-6.
18. Schrevens L, Vansteenkiste J, Deneffe G, de Leyn P, Verbeken E, Vandenberghe T, Demedts M. Clinical- radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: A long-term single institution experience. Lung Cancer 2004;43(1):39-45.
19. Detterbeck FC. Management of carcinoid tumors. Ann Thorac Surg 2010;89:998-1005.
20. Phan AT, Oberg K, Choi J, Harrison LH, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ. North American Neuroendocrine Tumor Society (NANETS) consensus guideline for the diagnosis and management of neuroendocrine tumors: Well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas 2010;39:784-98.